Position in PRLD
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$220,606
+$215,222 QoQ
Shares Held
64,505
+3373.6% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. PRLD ranks #329 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in PRLD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $220,606 | 64,505 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $5,384 | 1,857 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $6,005 | 4,171 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $84,299 | 104,204 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $73,846 | 96,156 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $85,921 | 67,390 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $14,523 | 7,016 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $41,657 | 10,934 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $74,204 | 15,655 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $84,856 | 19,873 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $22,890 | 7,408 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $31,013 | 6,892 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,585 | 980 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $6,263 | 1,037 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $449 | 68 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $14,124 | 2,706 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,262 | 183 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $24,127 | 1,938 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,156,280 | 37,001 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $216,671 | 7,568 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $967,817 | 22,336 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $184,669 | 2,581 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $42,874 | 1,423 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||